cyclic adenosine monophosphate levels were reduced in uninvolved myocardium ( 0.31 +/- 0.01 and 0.24 +/- 0.02 versus 0.43 +/- 0.02 nmol/g fresh weight ) and in the ischemic myocardium ( 0.38 +/- 0.02 and 0.34 +/- 0.04 versus 0.65 +/- 0.05 nmol/g ) in hearts treated respectively with 5.0 and 7.5 mumol/liter labetalol versus control hearts .
C0027061
myocardium
C0018787
hearts